Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs intravenous ondansetron for prevention of postoperative nausea and vomiting after cesarean section with spinal anesthesia
IRCT201212162080N13Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of ondansetron in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoint: Incidence of postoperative nausea and vomiting. Started Dec 2012; status: completed.
02
Drugs
ondansetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT201212162080N13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201212162080N13.